Glaxosmithkline
GSK credits STEER for Horlicks technology after year-long IP battle
India considers incentives for Tesla, 323 others to set up shop in country
GSK Consumer's pre-tax profit up 6% in Q2 on controlled raw material costs
GSK suspends sale of antacid Zinetac after USFDA issues advisory
Drug major GSK sold off up to 10 tail-end brands in FY19 including Celin

Bharat Biotech to buy GSK's Indian arm that produces anti-rabies vaccine